Enzyme Induction < Enzyme Inhibitors < Enzyme Precursors

Facettes : Author.f Mesh.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
000483 (2003)	Xiang Xu [République populaire de Chine] ; Yunqing Liu ; Susan Weiss ; Eddy Arnold ; Stefan G. Sarafianos ; Jianping Ding	Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
000520 (2004)	John Oxford [Royaume-Uni] ; Shobana Balasingam [Royaume-Uni] ; Rob Lambkin [Royaume-Uni]	A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community
000591 (2004)	Paul Towler [États-Unis] ; Bart Staker ; Sridhar G. Prasad ; Saurabh Menon ; Jin Tang ; Thomas Parsons ; Dominic Ryan ; Martin Fisher ; David Williams ; Natalie A. Dales ; Michael A. Patane ; Michael W. Pantoliano	ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis.
000769 (2004)	Usman Bacha [États-Unis] ; Jennifer Barrila ; Adrian Velazquez-Campoy ; Stephanie A. Leavitt ; Ernesto Freire	Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.
000B18 (2003)	J S Oxford [Royaume-Uni] ; A. Mann ; R. Lambkin	A designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu).
000C54 (2004)	Ya-Jen Chang [Taïwan] ; Catherine Y-Y Liu ; Bor-Luen Chiang ; Yu-Chan Chao ; Ching-Chow Chen	Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: identification of two functional regions.
000D62 (2004)	Yuan-Ping Pang [États-Unis]	Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding.
000D63 (2005)	Qishi Du [République populaire de Chine] ; Shuqing Wang ; Dongqing Wei ; Suzanne Sirois ; Kuo-Chen Chou	Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase.
000E66 (2005)	Julian A. Tanner [République populaire de Chine] ; Bo-Jian Zheng ; Jie Zhou ; Rory M. Watt ; Jie-Qing Jiang ; Kin-Ling Wong ; Yong-Ping Lin ; Lin-Yu Lu ; Ming-Liang He ; Hsiang-Fu Kung ; Andreas J. Kesel ; Jian-Dong Huang	The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus.
001222 (2006)	Yi-Ru Gan [République populaire de Chine] ; He Huang ; Yong-Dong Huang ; Chun-Ming Rao ; Yang Zhao ; Jin-Sheng Liu ; Lei Wu ; Dong-Qing Wei	Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.
001294 (2006)	Andrea J. Dooley [États-Unis] ; Nice Shindo ; Barbara Taggart ; Jewn-Giew Park ; Yuan-Ping Pang	From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus.
001330 (2006)	Pi-Hui Liang [Taïwan] ; Wei-Chieh Cheng ; Yi-Ling Lee ; Han-Pang Yu ; Ying-Ta Wu ; Yi-Ling Lin ; Chi-Huey Wong	Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.
001336 (2006)	Edward B. Thorp [États-Unis] ; Joseph A. Boscarino ; Hillary L. Logan ; Jeffrey T. Goletz ; Thomas M. Gallagher	Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity.
001376 (2006)	Joanna Zorzitto [Canada] ; Carole L. Galligan ; Joanna J M. Ueng ; Eleanor N. Fish	Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro.
001405 (2005)	Ting Xu [Singapour] ; Amy Ooi ; Hooi Chen Lee ; Rupert Wilmouth ; Ding Xiang Liu ; Julien Lescar	Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
001453 (2006)	D N Frick [États-Unis] ; A M I. Lam	Understanding helicases as a means of virus control.
001654 (2006)	Marcin Hoffmann [Pologne] ; Krystian Eitner ; Marcin Von Grotthuss ; Leszek Rychlewski ; Ewa Banachowicz ; Tomasz Grabarkiewicz ; Tomasz Szkoda ; Andrzej Kolinski	Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors.
001702 (2006)	Graham Simmons [États-Unis] ; Andrew J. Rennekamp ; Paul Bates	Proteolysis of SARS-associated coronavirus spike glycoprotein.
001915 (2008)	Valerie Grum-Tokars [États-Unis] ; Kiira Ratia ; Adrian Begaye ; Susan C. Baker ; Andrew D. Mesecar	Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.
001A23 (2007)	Nan Yang [République populaire de Chine] ; Julian A. Tanner ; Bo-Jian Zheng ; Rory M. Watt ; Ming-Liang He ; Lin-Yu Lu ; Jie-Qing Jiang ; Ka-To Shum ; Yong-Ping Lin ; Kin-Ling Wong ; Marie C M. Lin ; Hsiang-Fu Kung ; Hongzhe Sun ; Jian-Dong Huang	Bismuth complexes inhibit the SARS coronavirus.
001A97 (2007)	Nan Yang [République populaire de Chine] ; Julian A. Tanner ; Zai Wang ; Jian-Dong Huang ; Bo-Jian Zheng ; Nianyong Zhu ; Hongzhe Sun	Inhibition of SARS coronavirus helicase by bismuth complexes.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Enzyme Inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Enzyme Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Enzyme Inhibitors
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021